U.S. adults who would hypothetically get a coronavirus vaccine October 2020, by age

Proportion of adults who would get a coronavirus vaccine if it became available in the U.S. as of October 2020, by age group

Characteristic18 to 34 years35 to 44 years45 to 64 years65 years and older
Yes 44% 54% 48% 62%
No 32% 24% 26% 15%
Don't know/no opinion 24% 22% 27% 23%
Created with Highcharts 7.2.2Percentage of respondents44%44%32%32%24%24%54%54%24%24%22%22%48%48%26%26%27%27%62%62%15%15%23%23%18 to 34 years35 to 44 years45 to 64 years65 years and olderYesNoDon't know/no opinion
0%10%20%30%40%50%60%70%
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

October 2020

Region

United States

Survey time period

October 29 to 31, 2020

Number of respondents

2,200 respondents

Age group

18 years and older

Method of interview

Online survey

Supplementary notes

Original question: "If a vaccine that protects from the coronavirus became available, would you get vaccinated, or not?"

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Leading companies trust Statista:
paypal google adobe pg samsung telekom

Related reports: Available to download in PDF or PPTX format

All datain one format
All data
in one format
Coronavirus: the pharma and medtech response

Everything on "Coronavirus: the pharma and medtech response" in one document: edited and divided into chapters, including detailed references.

Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on " Coronavirus: the pharma and medtech response "

Other statistics that may interest you Coronavirus: the pharma and medtech response

Pharma - before the pandemic

6

Treatments and vaccines

8

Focus: BioNTech and Moderna

7

Opinions on COVID-19 vaccines

6

Business impact

4

Medtech - before the pandemic

5

Ventilators and testing

7

Further related statistics

19

Discover Statista

Need help with using Statista for your research? Tutorials and first steps

Further Content: You might find this interesting as well

Do you have any questions about our business solutions?

We provide you with detailed information about our Professional Account.

Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Learn more about how Statista can support your business.